Home/Filings/4/0001415889-15-000153
4//SEC Filing

ACADIA PHARMACEUTICALS INC 4

Accession 0001415889-15-000153

$ACADCIK 0001070494operating

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 6:03 PM ET

Size

13.2 KB

Accession

0001415889-15-000153

Insider Transaction Report

Form 4
Period: 2015-01-13
Transactions
  • Sale

    Common Stock

    2015-01-13$35.00/sh11,905$416,6768,500 total(indirect: See footnote)
  • Exercise/Conversion

    Common Stock

    2015-01-13$15.02/sh+4,685$70,36913,185 total(indirect: See footnote)
  • Exercise/Conversion

    Stock option (right to buy)

    2015-01-134,6850 total(indirect: See footnote)
    Exercise: $15.02Exp: 2017-06-14Common Stock (4,685 underlying)
  • Exercise/Conversion

    Common Stock

    2015-01-13$8.49/sh+7,220$61,29820,405 total(indirect: See footnote)
  • Exercise/Conversion

    Stock option (right to buy)

    2015-01-137,2202,780 total(indirect: See footnote)
    Exercise: $8.49Exp: 2018-06-12Common Stock (7,220 underlying)
Footnotes (5)
  • [F1]Shares and options are held by Morgan Management Aps, a Danish corporation in which Mr. Rasmussen has a controlling interest.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2014.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.01 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
  • [F4]25% of the shares subject to the stock option vested and became exercisable at the end of each 3-month period following the date of grant of June 15, 2007.
  • [F5]25% of the share subject to the stock option vested and became exercisable at the end of each 3-month period following the date of grant of June 13, 2008.

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070494

Filing Metadata

Form type
4
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 6:03 PM ET
Size
13.2 KB